Investment Thesis
Aethlon Medical is a pre-commercial or severely distressed medtech company with only $97.1K in annualized revenue against $7.2M net losses and negative $7.0M operating cash flow, indicating unsustainable burn. With negative margins exceeding -7300% and only $5.0M in cash reserves, the company requires immediate commercialization success or significant capital injection to avoid depletion of resources.
Strengths
- Strong liquidity position with 3.85x current ratio and $5.0M cash on hand
- Zero long-term debt, minimizing financial obligations
- Minimal capital expenditure ($3.7K) suggests already-developed product or pre-launch stage
Risks
- Catastrophic cash burn of $7.0M annually against $97.1K revenue with no profitability path visible
- Operating losses of $7.3M represent -7509% operating margin indicating fundamental business model failure at current scale
- Cash runway exhaustion likely within 8-12 months at current burn rate, necessitating dilutive financing or bankruptcy
- Negative ROE of -146.4% and ROA of -112.9% demonstrate value destruction for shareholders
Key Metrics to Watch
- Quarterly revenue growth trajectory and customer acquisition
- Monthly cash burn rate and updated cash runway estimate
- Operating expense reduction initiatives or new financing announcements
Financial Metrics
Revenue
97.1K
Net Income
-7.2M
EPS (Diluted)
$-10.61
Free Cash Flow
-7.0M
Total Assets
6.3M
Cash
5.0M
Profitability Ratios
Gross Margin
N/A
Operating Margin
-7,509.0%
Net Margin
-7,362.6%
ROE
-146.4%
ROA
-112.9%
FCF Margin
-7,208.8%
Balance Sheet & Liquidity
Current Ratio
3.85x
Quick Ratio
3.85x
Debt/Equity
0.00x
Debt/Assets
22.8%
Interest Coverage
-721.50x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-06-12T07:33:23.161069 |
Data as of: 2026-03-31 |
Powered by Claude AI